Non-scientific drug prescription in demented older people living in the community: An Italian perspective

Clinical Drug Investigation

Volumn 21, Issue 2, 2001, Pages 157-160

  Landi, F ^a   Onder, G ^a   Zuccala, G ^a   Russo, A ^a   Lattanzio, F ^b   Cesari, M ^a   Bernabei, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; NIMODIPINE; NOOTROPIC AGENT; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DEMENTIA; DRUG EFFICACY; ELDERLY CARE; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0035091349     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121020-00008     Document Type: Article

References (20)

1. Alzheimer disease research comes of age. The pace accelerated
2. Pharmacotherapy of Alzheimer disease: New drugs and novel strategies
3. The cholinergic hypothesis of Alzheimer's disease: A review of progress
4. Cholinergic markers in elderly patients with early signs of Alzheimer disease
5. Treatment of Alzheimer's disease
6. A model for integrated home care of frail older patients: The Silver Network Project
7. The Minimum Data Set for Home Care: A valid instrument to assess frail older people living in community
8. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease
9. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease
10. A controlled trial of tacrine in Alzheimer's disease in a community population of older persons
11. Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality
12. Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer's disease
13. Donepezil improves cognition and global function in Alzheimer disease. A 15-week, double-blind, placebo-controlled study
14. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
15. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
16. Is general practitioner decision-making associated with patient socio-economic status?
17. Use of unproven therapies by people with Alzheimer's disease
18. Physician motivations for nonscientific drug prescribing
19. Correlates of delayed referral for the diagnosis of dementia in an outpatient population